Castleark Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-183,340
Closed -$5.46M 287
2022
Q2
$5.46M Buy
+183,340
New +$5.27M 0.29% 80
2017
Q3
Sell
-41,640
Closed -$2.41M 386
2017
Q2
$2.41M Sell
41,640
-3,520
-8% -$204K 0.08% 233
2017
Q1
$2.64M Buy
45,160
+1,670
+4% +$94.7K 0.08% 252
2016
Q4
$2.42M Sell
43,490
-31,315
-42% -$1.67M 0.08% 249
2016
Q3
$3.52M Buy
+74,805
New +$3.56M 0.11% 218
2016
Q1
Sell
-29,430
Closed -$2.34M 369
2015
Q4
$2.34M Sell
29,430
-1,420
-5% -$99.4K 0.07% 250
2015
Q3
$1.81M Sell
30,850
-1,000
-3% -$66K 0.06% 255
2015
Q2
$2.05M Sell
31,850
-138,500
-81% -$8.48M 0.05% 277
2015
Q1
$10.4M Buy
170,350
+111,000
+187% +$7.58M 0.25% 127
2014
Q4
$3.48M Buy
+59,350
New +$3.02M 0.09% 189

Other funds holding ALKS

Castleark Management's ALKS Position: Q3 2022 in Review

Castleark Management sold out of Alkermes (ALKS) in Q3 2022, closing a stake of 183,340 shares — an estimated $5.46M sold.

Castleark Management first reported a position in ALKS in Q4 2014 and held it in 10 quarters. The position peaked at $10.4M in Q1 2015. 275 funds tracked by Wall St. Rank hold ALKS as of Q3 2022.

  • Castleark Management reported no remaining Alkermes position as of Q3 2022 after selling out during the quarter.
  • Castleark Management sold 183,340 Alkermes shares in Q3 2022, an estimated $5.46M.
  • Castleark Management first reported a position in Alkermes in Q4 2014 and held it in 10 quarters.
  • Castleark Management's Alkermes position peaked at $10.4M in Q1 2015.
  • 275 funds tracked by Wall St. Rank held Alkermes as of Q3 2022.

Based on Castleark Management's 13F filing for Q3 2022, filed 15 Nov 2022.